EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 3.0

Cardiopulmonary Event Prevalence Before First Recorded COPD Diagnosis: A Retrospective Cohort Study Using the Clinical Practice Research Datalink

Richard E K Russell iD, Vishnav Pradeep, Jonathan A Patrick, Christopher Llewellyn Morgan, Hungta Chen, Michael Pollack iD, Stephanie Dods, Hana Müllerová iD, Claus Franz Vogelmeier, Dave Singh, Chris P Gale iD, Della Varghese

International Journal of Chronic Obstructive Pulmonary Disease · 2026-11 · Volume 21 · 1-15

DOI: 10.2147/copd.s626824 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2026-11. Verfasst von Richard E K Russell und 11 weiteren Autor:innen. Beteiligte Einrichtung: King's Centre for Lung Health, Peter Gorer Department of Immunobiology, King's College London, London, UK. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Cardiovascular Diseases. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveCardiovascular DiseasesHumansRetrospective StudiesMaleAgedFemalePrevalenceMiddle AgedDatabases, FactualRisk FactorsTime FactorsRisk AssessmentUnited Kingdom

Stichwörter der Autor:innen

atrial fibrillationcardiac arrestcardiovascular comorbidityearly detectionexacerbationheart failureischaemic strokelower respiratory tract infectionmyocardial infarctionrevascularisationtachyarrhythmia

Autor:innen und Institutionen

  • King's Centre for Lung Health, Peter Gorer Department of Immunobiology, King's College London, London, UK.
  • Data Analytics, Human Data Sciences, Cardiff, UK.
  • Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA.
  • Respiratory Evidence Strategy, Biopharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA.
  • Global Medical Respiratory, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.
  • Respiratory Evidence Strategy, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.

ORCID-Profile: Richard E K Russell, Michael Pollack, Hana Müllerová, Chris P Gale

Zitieren

APA

Russell, R. E. K., Pradeep, V., Patrick, J. A., Morgan, C. L., Chen, H., Pollack, M., Dods, S., Müllerová, H., Vogelmeier, C. F., Singh, D., Gale, C. P., & Varghese, D. (2026). Cardiopulmonary Event Prevalence Before First Recorded COPD Diagnosis: A Retrospective Cohort Study Using the Clinical Practice Research Datalink. International Journal of Chronic Obstructive Pulmonary Disease, Volume 21, 1-15. https://doi.org/10.2147/copd.s626824

Vancouver

Russell REK, Pradeep V, Patrick JA, Morgan CL, Chen H, Pollack M, et al. Cardiopulmonary Event Prevalence Before First Recorded COPD Diagnosis: A Retrospective Cohort Study Using the Clinical Practice Research Datalink. International Journal of Chronic Obstructive Pulmonary Disease. 2026;Volume 21:1-15. doi:10.2147/copd.s626824

BibTeX
@article{Russell2026,
  author = {Russell, Richard E K and Pradeep, Vishnav and Patrick, Jonathan A and Morgan, Christopher Llewellyn and Chen, Hungta and Pollack, Michael and Dods, Stephanie and Müllerová, Hana and Vogelmeier, Claus Franz and Singh, Dave and Gale, Chris P and Varghese, Della},
  title = {Cardiopulmonary Event Prevalence Before First Recorded COPD Diagnosis: A Retrospective Cohort Study Using the Clinical Practice Research Datalink},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  year = {2026},
  volume = {Volume 21},
  pages = {1--15},
  doi = {10.2147/copd.s626824}
}
Kostenlos starten →